Kerecis

Kerecis is an Icelandic company that uses fish skins to treat wounds.[1][2] Fertram Sigurjonsson is the current chief executive officer (CEO) of Kerecis.[3][4]

Kerecis
TypePrivate
Founded2010 (2010)
FounderFertram Sigurjonsson
Headquarters
Ísafjörður
,
Iceland
Area served
Iceland, Switzerland, and United States
Key people
Fertram Sigurjonsson (CEO)
Products
  • Omega3 Wound
  • Omega3 SurgiBind
SubsidiariesPhytoceuticals AG
Websitekerecis.com

Kerecis has subsidiaries in Switzerland and the United States.[5] It is based in Ísafjörður, Iceland.[6][7]

In 2021, as per Morgunbladid report, the company was valued at more than 100 million euros.[8] Kereceis also works on medical research with the US Armed Forces and provides the grafts to branches of the military.[2][9]

History

Fertram Sigurjonsson observed in 2009 that the skin of the fish and qualities, which are similar to those of human skin, expedited the latter's regeneration, particularly in the case of acute or chronic wounds.[2][10] Based on his discovery, he founded Kereceis in 2013.[11]

In 2016, Omega3 Wound, a fish skin treatment developed by Kereceis, was approved by the US Food and Drug Administration.[12][13] In the same year, Kerecis established headquarters in Arlington, Virginia.[14]

In 2019, Kerecis acquired Phytoceuticals AG, a Swiss company active in the life sciences sector, that has since changed its name to Kerecis AG.[14] In the same year, Emerson Collective acquired a stake in Kerecis.[15][16]

In 2020, Kerecis received an award given by Vaxtarsprotinn, a joint project of the Confederation of Icelandic Industries, the Confederation of Start-up Companies, Icelandic Research Center, and Reykjavík University.[11]

In 2021, FDA approved Kerecis Omega3 SurgiBind, fish-skin for surgical use that is useful in plastic and reconstructive surgery.[6]

References
  1. Hannan, Daniel (October 25, 2020). "Taking back control of fishing could be an enormous growth opportunity for Britain". The Daily Telegraph.
  2. "Dans le poisson islandais, rien ne se perd, tout se transforme". Le Monde. October 16, 2021.
  3. "Kerecis allt að 30 milljarða króna virði". Morgunblaðið.
  4. "Kerecis bíður færis á yfirtökum". Fréttablaðið.
  5. "Ólafur Ragnar kominn í stjórn Kerecis". Fréttablaðið.
  6. "FDA Approves Kerecis' Implantable Fish-Skin Product". Iceland Monitor.
  7. "Tekjur Kerecis þrefaldist og verði þrír milljarðar". Fréttablaðið.
  8. "Dans le poisson islandais, rien ne se perd, tout se transforme". October 16, 2021 – via Le Monde.
  9. Torrance, Jack (June 24, 2018). "Iceland: From crisis to hotspot, 10 years on from the financial crisis". The Telegraph.
  10. "Biotech Company Kerecis to Be Listed Abroad". Iceland Monitor.
  11. "Kerecis valið Vaxtarsproti ársins". Morgunblaðið.
  12. "Fish Skin for Human Wounds: Iceland's Pioneering Treatment". Bloomberg Businessweek.
  13. "Alaska's seafood industry by the numbers, plus fish skin's medical applications and antibiotics in Chilean salmon". Anchorage Daily News.
  14. Lake, Sydney (January 25, 2021). "Arlington biotech company names CFO".
  15. "Ólafur Ragnar í stjórn Kerecis". Fréttablaðið.
  16. "Emerson Collective eignast hlut i Kerecis". Fréttablaðið.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.